View Author
dai: 074511866
scopus: 7005090997

Rutten-van Mölken, M.P.M.H.

(Maureen Rutten-van Mölken)

Supervisor (promotor) of 2 dissertations


patient health study exacerbation disease treatment group intervention model trial value outcome effect result cost-effectiveness difference number analysis utility change quality smoking hospital mortality function tiotropium table score salmeterol netherland respir questionnaire asthma kosten estimate practice scenario severity probability lung function evaluation cessation measure ratio symptom population state information method guideline parameter month copd patients dutch kousen baseline research worden exercise analyses smoker period improvement journal country medication therapy scale elastische measurement management visit decision distribution uncertainty resource time horizon veneuze sensitivity stage




10 Most Recent Publications

Patient preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: Results of a randomised controlled trial (Article)
Utens, C.M.A. Goossens, L.M.A. Schayck, O. van Rutten-van Mölken, M.P.M.H. Litsenburg, W. van Janssen, A. Pouw, A. van der Smeenk, F.W.J.M.
2013-04-11
Inquiry into the relationship between equity weights and the value of the QALY (Article)
Bobinac, A. Exel, N.J.A. van Rutten-van Mölken, M.P.M.H. Brouwer, W.B.F.
2012-12-01
Goud op de 100 meter HTA: van zorginnovaties voor chronisch zieken (Inaugural Lecture)
Rutten-van Mölken, M.P.M.H.
2012-06-22
Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: A review of the evidence and methodological issues (Article)
Rutten-van Mölken, M.P.M.H. Goossens, L.M.A.
2012-03-19
GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation (Article)
Bobinac, A. Exel, N.J.A. van Rutten-van Mölken, M.P.M.H. Brouwer, W.B.F.
2012-01-01
Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: Results of a randomised controlled trial (Article)
Utens, C.M.A. Goossens, L.M.A. Smeenk, F.W.J.M. Rutten-van Mölken, M.P.M.H. Vliet, van M. Braken, M. Eijsden, L. van Schayck, O. van
2012-01-01
The Role of Value-of-Information Analysis in a Health Care Research Priority Setting: A Theoretical Case Study (Article)
Corro Ramos, I. Rutten-van Mölken, M.P.M.H. Al, M.J.
2012-01-01
Which long-acting bronchodilator is most cost-effective for the treatment of COPD (Article)
Hoogendoorn, M. Kappelhoff, B.S. Overbeek, J.A. Wouters, E.F.M. Rutten-van Mölken, M.P.M.H.
2012-01-01
Naar gepast gebruik van geneesmiddelen (Article)
Rutten-van Mölken, M.P.M.H. Uyl-de Groot, C.A.
2012-01-01
The potential for integrated care programmes to improve quality of care as assessed by patients with COPD: early results from a real-world implementation study in The Netherlands (Article)
Cramm, J.M. Rutten-van Mölken, M.P.M.H. Nieboer, A.P.
2012-01-01